Waystar Holding Corp.: insider trades · United States · SEC (Form 4)

About Waystar Holding Corp.

Waystar Holding Corp. (ticker: WAY) is a U.S.-based healthcare software company listed on the Nasdaq market in the United States. For French-speaking investors, it is best understood as a B2B infrastructure provider sitting at the center of healthcare payment workflows and revenue cycle management for hospitals, physician groups, and other care providers. The company was originally incorporated in Delaware in August 2019, adopted the Waystar Holding Corp. name in August 2023, and completed its initial public offering in June 2024. Its principal offices are co-located in Lehi, Utah, and Louisville, Kentucky, underscoring a dual operational footprint in two major U.S. health-tech hubs. Waystar’s core business is a cloud-native software platform designed to simplify healthcare payments, reduce manual work, and improve providers’ financial performance. Its product suite spans patient access, claims management, payment processing, collections, denial prevention, and more recently AI-driven capabilities, including agentic and generative AI use cases. The company describes its enterprise-grade platform as processing more than 7.5 billion healthcare payment transactions annually, with over $2.4 trillion in annual gross claims, reaching approximately 60% of U.S. patients and one in three U.S. hospital discharges. These figures, highlighted by the company, illustrate the scale and embeddedness of its network, although investors should note they are company-reported metrics. From a competitive standpoint, Waystar is positioned as a leading revenue cycle management platform in a fragmented but mission-critical category. Its differentiation is based on software depth, workflow integration, automation, and an expanding AI layer. The company has also built meaningful brand credibility through repeated Best in KLAS recognition and several innovation awards tied to AI capabilities. Another milestone was its addition to the S&P SmallCap 600 index in September 2025, which typically increases visibility among institutional investors and index-tracking funds. Recent strategic developments have been particularly important. In July 2025, Waystar announced a definitive agreement to acquire Iodine Software for an enterprise value of $1.25 billion, a move aimed at strengthening its AI-powered transformation of healthcare payments. In 2026, the company continued to emphasize AI-led product expansion, including an expanded collaboration with Google Cloud in March and the launch in April of a solution targeting so-called “silent denials,” a large and often under-recognized source of provider revenue leakage. Overall, Waystar looks like a growth-oriented healthcare technology franchise with exposure to the U.S. market’s ongoing shift toward automated, data-driven payment infrastructure.